ClinicalTrials.gg
RecruitingNCT07845136Updated Sep 28, 2026

The Effect of a Riddle-Based Distraction Technique on Pain, Fear, and Anxiety During Cast Application in Children: A Randomized Study

An interventional study of Riddle-Based Distraction in Casting and Fracture Dislocation, sponsored by Artvin Coruh University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Artvin Coruh University · Not applicable, Interventional, and Supportive care

How we know

Updated Sep 28, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,722 studies in Pain with a site in Turkey — 321 open to participants now, 374 under way, none of them phase 3. Pain · Turkey.

Planned enrollment
763rd of 1,499
68 · median 70
Started
2026
with 185 others
No phase
1,457 of 1,722
259 open now
Primary completion
2027-02
later than 317 of 373 live
Registered
1,681st of 1,722
by date

Among the 1,722 studies in Pain with a site in Turkey, this one is the 763rd largest by planned enrollment of the 1,499 interventional ones that give a count, is one of 186 that started in 2026, is one of 1,457 with no phase, reaches primary completion later than 317 of the 373 other live ones, and was the 1,681st registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

321 of the 1,722 studies in Pain with a site in Turkey are open now. Recruiting first, the newest first:

315 more — sign in →

All 321 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 6 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,722 studies in Pain with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to determine the effect of a riddle-based distraction intervention, administered during cast application in children, on levels of pain, fear, and anxiety.

Read the detailed description

Thirty-eight volunteer children aged 6-12 presenting to the Emergency Department Green Zone Cast Room at hospital for cast application (upper or lower extremity) will be randomly divided into two groups: intervention (riddle-based distraction) and control group. Children will be assessed before and during/after the procedure. Pain related to the cast application will be assessed with the Wong-Baker Faces Pain Scale, fear with the Child Fear Scale, and anxiety levels with the State-Trait Anxiety Inventory for Children (STAIC). In addition, children's sociodemographic and clinical data will be recorded in the Information Form.

03

Conditions studied

  • Casting
  • Fracture Dislocation

Keywords

  • Pain
  • Fear
  • Anxiety
  • Cast Application
  • Pediatric Patients
04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between 6 and 12 years of age
  • Scheduled for cast application (upper or lower extremity)
  • Conscious and able to communicate
  • Able to understand and speak Turkish
  • Having no auditory or cognitive impairments
  • Having no prior exposure to a similar non-pharmacological distraction intervention
  • Willingness of both the child and parent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Being under the influence of analgesic, sedative, or anxiolytic medication
  • Having severe trauma or an unstable clinical condition requiring emergency intervention
  • Presence of developmental delay, neurological disease, or conditions affecting communication
  • Inability to participate in riddles due to hearing or visual impairment
  • Having prior cast experience on the same extremity
  • Inability to cooperate during the research process
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
68 participants (estimated)

Study arms

  • No intervention
    Control Group

    Routine clinical care will be applied to the control group. No action will be taken.

  • Experimental
    Experimental Group

    Before and during the cast application, the child will be asked age-appropriate simple riddles, encouraged to actively participate through clues, and their attention will be distracted from the procedure.

    Other: Riddle-Based Distraction

Interventions

  • OtherRiddle-Based Distraction

    Children who come to the hospital's cast room and meet the research criteria will be randomly assigned to the intervention group. The baseline scales and information forms will be filled out by the researcher through interviews with the child and parent before the cast application. Before the research, a pool of short, clear, and age-appropriate riddles will be prepared in consultation with experts, taking into account the cognitive levels of children aged 6-12. Prior to the procedure, brief communication will be established with the child to introduce the riddle game. During the cast preparation (preparing materials and positioning the extremity) and throughout the entire cast application process (wrapping, shaping, and setting the cast), the researcher will continuously ask the child riddles. The child's active participation will be encouraged by providing hints when needed and offering positive feedback. Active distraction turns the frightening cast room into an engaging space.

06

What researchers measure

Primary outcomes

  1. Patient Identification Form

    It is a form consisting of 4 questions in total, including the child's age, gender, previous fracture experience, and if any, how many times the child has experienced a fracture. It was prepared by the researcher in accordance with the literature.

    Time frame: Baseline

  2. Wong-Baker FACES Pain Rating Scale

    This scale was developed by Donna Wong and Connie Moran Baker in 1981 to assess pain levels in children. Suitable for children aged 3-18 years, the scale consists of 6 facial expressions scored from '0' to '10'. A score of "0" indicates no pain, while a score of "10" represents the worst possible pain. In our study, the child will be shown the facial expressions on the scale, asked to choose the face that best describes their pain, and the corresponding score will be recorded.

    Time frame: Baseline and up to 4 weeks

  3. Child Fear Scale - CFS

    Developed by McMurtry and colleagues, the Turkish validity of this scale was conducted by Gerçeker and colleagues. The changes in the facial muscles of a frightened expression were drawn by a graphic artist from a photograph of a frightened face. The scale features facial expressions scored from 0 to 4, where "0" indicates a neutral expression (no fear), "1" indicates a very low level of fear, "2" indicates a little fear, "3" indicates a greater level of fear, and "4" indicates the highest level of fear. In our study, the child will be shown the facial expressions on the fear scale, asked to select how they feel, and the corresponding score will be recorded.

    Time frame: Baseline and up to 4 weeks

  4. State-Trait Anxiety Inventory for Children - STAIC / Thermometer

    Developed to measure anxiety in children, the Turkish validity of this tool was confirmed by Gerçeker and colleagues (Ayar et al.). The scale utilizes a thermometer visual with a bulb at the bottom representing a score of "0" and lines extending upwards divided into 10 sections reaching a score of "10". The child is explained that as their finger moves up from the bulb, their anxiety increases, whereas the bulb represents playing happily with friends. In our study, the child will be asked to point to the thermometer according to how they feel during the procedure, and the corresponding score will be recorded.

    Time frame: Baseline and up to 4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Akay G, Guducu Tufekci F. Storytelling Intervention Relieved Pain During Tracheostomy Suction in Children Under Palliative Care: A Randomised Controlled Trial. Scand J Caring Sci. 2026 Mar;40(1):e70182. doi: 10.1111/scs.70182. PubMed 41588469 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 3 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2026
First posted
Sep 28, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Feb 1, 2027
CompletionEst.
May 1, 2027
Last update
Sep 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 28, 2026
Show all 1 update
  1. Sep 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07845136
Lead sponsor
Artvin Coruh University
Responsible party
Gamze Akay (Assistant Professor, Artvin Coruh University) — Principal investigator
First posted
Sep 28, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Feb 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Sep 28, 2026

Study contacts

Gamze AKAY, 1
Contact
gamzeakay_25@artvin.edu.tr
05314536661
Elif Simay KOÇ, 2
Contact
elifsimay.koc@kilis.edu.tr
903488142666
Gamze AKAY, 1
principal investigator · Artvin Coruh University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion